Mangal Compusolution IPO vs Onyx Biotec IPO

Comparision between Mangal Compusolution IPO and Onyx Biotec IPO.

IPO Details

Mangal Compusolution IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Onyx Biotec IPO is a SME Book Built Issue proposed to list at NSE SME.

	Mangal Compusolution IPO	Onyx Biotec IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Jawa Capital Services Private Limited	Horizon Management Private Limited
Registrar	Kfin Technologies Limited	Mas Services Limited
Market Maker	Rikhav Securities Limited	Giriraj Stock Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Mangal Compusolution IPO is up to ₹16.23 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹29.34 Cr. The final issue price of Mangal Compusolution IPO is ₹45.00 per share and of Onyx Biotec IPO is ₹61.00 per share.

	Mangal Compusolution IPO	Onyx Biotec IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹58.00 per share
Issue Price (Upper)		₹61.00 per share
Issue Price (Final)	₹45.00 per share	₹61.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	3000 shares	2000 shares
Fresh Issue Size	36,06,000 shares	48,10,000 shares
Fresh Issue Size (Amount)	up to ₹16.23 Cr	up to ₹29.34 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	36,06,000 shares	48,10,000 shares
Issue Size Total (Amount)	up to ₹16.23 Cr	up to ₹29.34 Cr

IPO Timetable

Mangal Compusolution IPO opens on Nov 12, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Mangal Compusolution IPO and Onyx Biotec IPO is Nov 14, 2024, and Nov 18, 2024, respectively.

	Mangal Compusolution IPO	Onyx Biotec IPO
Anchor Bid Date		Nov 12, 2024
Issue Open	Nov 12, 2024	Nov 13, 2024
Issue Close	Nov 14, 2024	Nov 18, 2024
Basis Of Allotment (Tentative)	Nov 18, 2024	Nov 19, 2024
Initiation of Refunds (Tentative)	Nov 19, 2024	Nov 20, 2024
Credit of Share (Tentative)	Nov 19, 2024	Nov 20, 2024
Listing date (Tentative)	Nov 21, 2024	Nov 22, 2024
Anchor Lockin End date 1		Dec 19, 2024
Anchor Lockin End date 2		Feb 17, 2025

Financials

Mangal Compusolution IPO P/E ratio is 11.66, as compared to Onyx Biotec IPO P/E ratio of 26.81.

Mangal Compusolution IPO

Onyx Biotec IPO

Financial

Mangal Compusolution Limited Financial Information (Restated)

Mangal Compusolution Limited's revenue decreased by -32.69% and profit after tax (PAT) dropped by -45.21% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	30 Jun 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	4,492.01	4,552.12	4,715.71	5,267.09
Revenue	453.44	2,344.42	3,483.18	1,848.78
Profit After Tax	80.97	385.80	704.09	86.62
Net Worth	2,080.88	1,999.90	1,614.10	910.00
Reserves and Surplus	1,080.88	999.90	1,414.10	710.00
Total Borrowing	1,862.75	2,041.21	2,652.30	3,434.12
Amount in ₹ Lakhs

Onyx Biotec Limited Financial Information (Restated)

Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 May 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,476.57	7,413.58	5,872.36	3,683.84
Revenue	1,054.11	5,387.43	3,961.65	4,498.09
Profit After Tax	130.77	303.16	184.46	335.29
Net Worth	2,618.64	2,487.87	1,820.16	1,637.59
Reserves and Surplus	1,286.42	1,155.65	1,230.00	1,047.43
Total Borrowing	3,156.14	3,078.04	2,922.83	1,224.39
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100.00%

88.60%

Promoter Shareholding (Post-Issue)

73.50%

P/E Ratio

11.66

26.81

Market Cap

₹61.23 Cr.

₹110.61 Cr.

ROE

3.97%%

4.99%%

ROCE

2.05%%

3.71%%

Debt/Equity

0.9

1.21

EPS

₹3.86

₹2.28

RoNW

15.56%%

4.99%%

Shares Offered

In the Mangal Compusolution IPO retail investors (RII) are offered 17,10,000 shares while in Onyx Biotec IPO retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Mangal Compusolution IPO and 9,12,000 shares in Onyx Biotec IPO.

	Mangal Compusolution IPO	Onyx Biotec IPO
Anchor Investor Reserveration		13,66,000 shares
Market Maker Reserveration	1,86,000 shares	2,44,000 shares
QIB	0 shares	9,12,000 shares
NII	17,10,000 shares	6,88,000 shares
RII	17,10,000 shares	16,00,000 shares
Employee	0 shares	0 shares
Others
Total	34,20,001 shares	32,00,000 shares

Bids Received (Subscription)

Mangal Compusolution IPO subscribed 34.59x in total, whereas Onyx Biotec IPO subscribed 198.00x.

	Mangal Compusolution IPO	Onyx Biotec IPO
QIB (times)		32.49x
NII (times)	22.28x	602.86x
Big NII (times)
Small NII (times)
RII (times)	46.91x	118.26x
Employee (times)
Other (times)
Total (times)	34.59x	198.00x

Compare with others

Mangal Compusolution IPO	Onyx Biotec IPO
Rajesh Power Services IPO	Rajputana Biodiesel IPO
C2C Advanced Systems IPO	Rajesh Power Services IPO
Lamosaic India IPO	C2C Advanced Systems IPO
Nisus Finance Services IPO	Lamosaic India IPO
Onyx Biotec IPO	Nisus Finance Services IPO
Rosmerta Digital Services IPO	Mangal Compusolution IPO
Neelam Linens and Garments IPO	Rosmerta Digital Services IPO
OBSC Perfection IPO	Neelam Linens and Garments IPO
United Heat Transfer IPO	OBSC Perfection IPO
Danish Power IPO	United Heat Transfer IPO

Comments

Add a public comment...